FindTrial
Sign In

Potentially operable pancreatic tumors and outcomes

Borderline resectable pancreatic tumors: outcomes of multimodality approach

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/10/010050
Enrollment
40
Registered
2017-10-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Borderline resectable pancreatic tumors

Interventions

None listed

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Radiologically defined borderline resectable pancreatic tumors

Exclusion criteria

Exclusion criteria: 1) Metastatic tumors 2) PS 2 and above 3) Liver and renal function criteria precluding any form of neoadjuvant treatment 4) Previous history of any malignancy, cardiac or respiratory disorder, which precludes any form of neoadjuvant treatment 5) Previously treated patient

Design outcomes

Primary

MeasureTime frame
Disease free and overall survival Timepoint: Retrospectively from January 2007 and prospectively for 12 months—

Secondary

MeasureTime frame
Resectability rate, postoperative outcome, Pattern of recurrencesTimepoint: January 2007 and prospectively for 12 months—

Countries

India

Contacts

Public ContactAbhishek Mitra

Tata Memorial Hospital

svsclinresearch@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026